182 Double Deckers from Volvo Buses to Dublin and London
November 08, 2005 03:04 ET
|
Volvo
GOTEBORG, Sweden, Nov. 8, 2005 (PRIMEZONE) -- Volvo Buses has received two orders for 182 double deckers. 120 of them will go into service in Dublin and the rest will run on three new bus routes in...
Vaisalan A-osakkeiden merkintä optio-oikeuksilla
November 08, 2005 03:00 ET
|
Vaisala Oyj
Vaisala Oyj Pörssi-ilmoitus 8.11.2005, 10.00 1(1)
Vaisalan vuoden 2000 optio-ohjelmaan liittyvillä optio-oikeuksilla 21.10.2005 mennessä merkityt uudet A-osakkeet, yhteensä 7 450...
Shares subscribed with warrants in Vaisala Group
November 08, 2005 03:00 ET
|
Vaisala Oyj
Vaisala Oyj Stock Exchange Announcement 8.11.2005 at 10.00 1(1)
By October 21, 2005, a total of 7 450 Vaisala A-shares were...
Invitation to Orion's Capital Markets Day
November 08, 2005 02:52 ET
|
Orion Oyj
Orion Corporation is holding a Capital Markets Day for investors and financial analysts on Tuesday, 22 November 2005, at 08.30 - 12.00, at the Grocers' Hall, address Princes Street, London EC2R 8AD....
AKSEPT AV OPSJONER
November 08, 2005 02:42 ET
|
Hexagon Composites ASA
Primærinnsidere i HEXAGON COMPOSITES ASA har akseptert tildeling av til sammen 755 000 opsjoner på kjøp av aksjer i selskapet.Styret besluttet i møte den 18. august 2005 tildeling av opsjoner i...
OMX Exchanges: TradeDoubler AB listed on Stockholm Stock Exchange
November 08, 2005 02:39 ET
|
OMX Exchanges
STOCKHOLM, Sweden, Nov. 8, 2005 (PRIMEZONE) --OMX Exchanges: As of today, the IT-company TradeDoubler AB is traded on Stockholm Stock Exchange's O List.
TradeDoubler is Europe's leading supplier of...
Active Biotech Commences Clinical Phase I Combination Study of ANYARA and Taxotere
November 08, 2005 02:38 ET
|
Active Biotech
STOCKHOLM and LUND, Sweden, Nov. 8, 2005 (PRIMEZONE) -- Active Biotech (Stockholm:ACTI) has commenced enrollment for a clinical Phase I combination study of its candidate drug, ANYARA, with the...
Active Biotech inleder klinisk fas I kombinationsstudie med ANYARA och Taxotere®
November 08, 2005 02:30 ET
|
Active Biotech
Denna dos-eskaleringsstudie, där mellan tjugo och trettio patienter kommer att ingå, ska studera ökande doser av ANYARA i kombination med en fast dos Taxotere®. Taxotere® kommer att administreras...
Active Biotech Commences Clinical Phase I Combination Study of ANYARA and Taxotere®
November 08, 2005 02:30 ET
|
Active Biotech
This dose-escalation study, expected to include between 20 and 30 patients, will examine the response to increasing doses of ANYARA in combination with a fixed dose of Taxotere®. Taxotere® will be...
Cable & Wireless -- Interviews with CEO and FD
November 08, 2005 02:20 ET
|
Cantos
LONDON, Nov. 8, 2005 (PRIMEZONE) -- Cable & Wireless -- interim results. Interviews available now on www.cantos.com with Francesco Caio, CEO, and Charles Herlinger, FD, Cable & Wireless...